“Aglaia identifies groundbreaking opportunities in cancer research and, in close partnerships with inventors and entrepreneurs, takes these opportunities to the next phase of technical and commercial development.”

 

 

In its commitment to create and build biomedical companies in the field of oncology, Aglaia does not only provide the financial means but also takes an active role in strategic and operational processes.

After the successful first fund, The Fund Manager - Aglaia BioMedical Ventures - is currently investing from its second fund: Aglaia Oncology Fund II Cooperatieve UA.

News & Events